CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Clinical ink Expands Digital Health Technology Portfolio with Sleep and Actigraphy Monitoring

Positive
AI Analysis

Summary

Clinical ink announced the expansion of its digital health technology portfolio with five new connected devices for sleep staging, home sleep apnea testing, and actigraphy monitoring integrated into its eClinical platform. This represents a routine product expansion with no material regulatory or clinical milestones.

Importance:2/10
Sentiment:
0.30
digital healthmedical deviceseClinical platformsleep monitoringactigraphyglucose monitoring
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on October 5, 2026 1:00 PM

Read Original